The Enterprise Value as of January 2026 (TTM) for Navidea Biopharmaceuticals, Inc. (NAVB) is 439.86K

According to Navidea Biopharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 439.86K. This represents a change of -92.66% compared to the average of 5.99M of the last 4 quarters.

Navidea Biopharmaceuticals, Inc. (NAVB) Historical Enterprise Value (quarterly & annually)

How has NAVB Enterprise Value performed in the past?

The mean historical Enterprise Value of Navidea Biopharmaceuticals, Inc. over the last ten years is 114.31M. The current 439.86K Enterprise Value has changed -61.52% with respect to the historical average. Over the past ten years (40 quarters), NAVB's Enterprise Value was at its highest in in the September 2015 quarter at 392.33M. The Enterprise Value was at its lowest in in the June 2023 quarter at -366876.94.

Navidea Biopharmaceuticals, Inc. (NAVB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Navidea Biopharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Navidea Biopharmaceuticals, Inc. (NAVB) Average Enterprise Value

How has NAVB Enterprise Value performed in the past?

The current Enterprise Value of Navidea Biopharmaceuticals, Inc. (NAVB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Navidea Biopharmaceuticals, Inc. (NAVB) Enterprise Value vs. Peers

How is NAVB’s Enterprise Value compared to its peers?

Navidea Biopharmaceuticals, Inc.’s Enterprise Value is less than Generex Biotechnology Corporation (11.22M), less than WPD Pharmaceuticals Inc. (542.80K), less than Nanomix Corporation (11.40M), greater than NeonMind Biosciences Inc. (0), less than Gelesis Holdings, Inc. (66.48M), less than MobileSmith, Inc. (4.87M), greater than Goodbody Health Limited (-5730953.53), less than Gene Biotherapeutics, Inc. (880.93K), less than MagForce AG (29.01M), less than Acorda Therapeutics, Inc. (161.36M),

Build a custom stock screener for Navidea Biopharmaceuticals, Inc. (NAVB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Navidea Biopharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Navidea Biopharmaceuticals, Inc. (NAVB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Navidea Biopharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.